Dr. Reddy's Laboratories Limited (DRREDDY) — Board Meeting | 24 October 2025(2 announcements)
Dr. Reddy's Laboratories' board approved the assignment of Chief Human Resources Officer (CHRO) responsibilities to Mr. Sanjay Sharma, Global Head Operations, effective December 1, 2025, following the resignation of Ms. Archana Bhaskar (effective November 30, 2025). Sharma brings 34 years of experience across FMCG and pharmaceuticals sectors, with credentials including an IIT Delhi chemical engineering degree and Harvard Business School's Advanced Management Program. This consolidation replaces an external hire with internal promotion.
Dr. Reddy's Laboratories reported Q2 FY26 revenue of ₹88.1 billion (9.8% YoY growth) and H1 FY26 revenue of ₹173.5 billion (10.6% YoY growth). Net profit grew 14% YoY in Q2 to ₹14.3 billion and 8% YoY in H1 to ₹28.4 billion. Gross margins compressed by 492 basis points YoY due to Lenalidomide sales reduction and generic price erosion. The company acquired STUGERON brand for $50.5 million and launched multiple new products across markets. An ongoing FCPA investigation regarding alleged improper payments in Ukraine remains under SEC/DOJ engagement.
About Dr. Reddy's Laboratories Limited (DRREDDY)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when DRREDDY files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track DRREDDY — Free💡 Ask AI about this filing
📊 More DRREDDY filings
- Announcement — 13 August 2026 Dr. Reddy's Laboratories announced the resignation of CEO Deepak Sapra from the Senior Management Pe...
- Announcement — 7 August 2026 Dr. Reddy's Laboratories announced termination of its distribution agreement with Novartis India eff...
- Announcement — 1 August 2026 Dr. Reddy's Laboratories announced that the U.S. FDA approved its rituximab biosimilar for the U.S. ...
- Announcement — 29 July 2026 Dr. Reddy's Laboratories announced that the US FDA completed a Pre-Approval Inspection and GMP check...
- Announcement — 29 July 2026 Dr. Reddy's Laboratories clarified on July 29, 2026 that a Business Standard news article about Thai...
🔥 Also filed on 24 October 2025
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DRREDDY files new disclosures
Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DRREDDY — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research